CoChat

Inflammation and Type 2 Diabetes: Results from KORA Augsburg

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes is associated with a systemic low-grade inflammation. First data provided by cross-sectional studies from as early as the 1960s demonstrated elevated systemic levels of glycoproteins and acute-phase reactants and increased leukocyte counts in type 2 diabetes patients. Subsequently, prospective studies showed that elevated concentrations of several acute-phase proteins and cytokines are predictive of later type 2 diabetes. Immune gene variants in man and in animal models were found to affect insulin resistance and diabetes incidence. Antidiabetic treatment by medication, diet or physical activity results in a significant decrease of systemic immune mediator concentrations. Immunological analyses of the KORA Survey S4 (1999/2001) allowed us to show that levels of circulating acute-phase proteins like CRP and of IL-6 are highly correlated and associated not only with overt type 2 diabetes, but already with impaired glucose tolerance (IGT) pointing out a role of these mediators in the pathogenesis of type 2 diabetes. On the contrary, TNFalpha was neither coregulated with CRP nor associated with diabetes status. Our study therefore shows that type 2 diabetes is accompanied by a non-random and differential upregulation of components of the innate immunity and suggests that this inflammatory condition is involved in the aetiology of the disease. Future work will extend the range of analysed immune mediators to chemokines and will also investigate the association of immune markers with indices of obesity to elucidate the relevance of this traditional risk factor for low-grade inflammation.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2005-858252

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Cited by

See all 100

Metadata

Authors
Herder, C., Illig, T., Rathmann, W., Martin, S., Haastert, B., Müller-Scholze, S., Holle, R., Thorand, B., Koenig, W., Wichmann, H., & Kolb, H.
Affiliations
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • Helmholtz Munich (DE)
Venue
Das Gesundheitswesen
Published
2005-07-20
Volume
67
Issue
S 01
Pages
115-121
ISSN
  • 0941-3790 (ISSN-L)
  • 1439-4421
OpenAlex
W2074266524
Cited by
97
References
42
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 1
FWCI
2.61
Type
journal article
Language
de
Open access
Locations
  • Das Gesundheitswesen (publishedVersion)
  • PubMed (publishedVersion)
  • Site cant be reached (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, low-grade inflammation, acute phase proteins, C-reactive protein, interleukin-6, TNF-α, impaired glucose tolerance, insulin resistance, innate immunity, cytokines, diabetes pathogenesis, obesity
MeSH terms
Acute-Phase Proteins, Adult, Aged, Diabetes Mellitus, Type 2, Female, Germany, Humans, Inflammation, Male, Middle Aged, Population Surveillance, Registries, Research Design, Risk Factors, Cohort Studies, Biomarkers, Comorbidity, Incidence, Survival Analysis, Case-Control Studies, Cytokines, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation and Type 2 Diabetes: Results from KORA Augsburg. https://app.cochat.ai/papers/10.1055/s-2005-858252
The paper
Herder, C., Illig, T., Rathmann, W., Martin, S., Haastert, B., Müller-Scholze, S., Holle, R., Thorand, B., Koenig, W., Wichmann, H., & Kolb, H. (2005). Inflammation and Type 2 Diabetes: Results from KORA Augsburg. Das Gesundheitswesen. https://doi.org/10.1055/s-2005-858252

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.